Functional delivery of HCN2/SkM1 via human CPCs demonstrated effectiveness in bradycardia models. In particular, the lentiviral transduction of HCN2 and SkM1 was more efficient than their nucleofection-mediated gene transfer. Moreover, virally transduced cells survived better in vivo. This evidence concerns the gene HCN2 and Bradycardia.